219 related articles for article (PubMed ID: 8417334)
1. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver.
Sandgren EP; Luetteke NC; Qiu TH; Palmiter RD; Brinster RL; Lee DC
Mol Cell Biol; 1993 Jan; 13(1):320-30. PubMed ID: 8417334
[TBL] [Abstract][Full Text] [Related]
2. Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
Thorgeirsson SS; Santoni-Rugiu E
Mutat Res; 1997 May; 376(1-2):221-34. PubMed ID: 9202759
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.
Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC
Cancer Res; 1995 Sep; 55(17):3915-27. PubMed ID: 7641211
[TBL] [Abstract][Full Text] [Related]
4. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
Thorgeirsson SS; Santoni-Rugiu E
Br J Clin Pharmacol; 1996 Jul; 42(1):43-52. PubMed ID: 8807143
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
7. Interactive effects of c-myc and transforming growth factor alpha transgenes on liver tumor development in simian virus 40 T antigen transgenic mice.
Enomoto A; Sandgren EP; Maronpot RR
Vet Pathol; 1998 Jul; 35(4):283-91. PubMed ID: 9684972
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
[TBL] [Abstract][Full Text] [Related]
11. Molecular analyses of liver tumors in c-myc transgenic mice and c-myc and TGF-alpha double transgenic mice.
Ohgaki H; Sanderson ND; Ton P; Thorgeirsson SS
Cancer Lett; 1996 Aug; 106(1):43-9. PubMed ID: 8827045
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the cooperative effects of transforming growth factor alpha and c-myc overexpression in rat liver epithelial cells.
Presnell SC; Thompson MT; Strom SC
Mol Carcinog; 1995 Aug; 13(4):233-44. PubMed ID: 7646762
[TBL] [Abstract][Full Text] [Related]
13. Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice.
Factor V; Oliver AL; Panta GR; Thorgeirsson SS; Sonenshein GE; Arsura M
Hepatology; 2001 Jul; 34(1):32-41. PubMed ID: 11431731
[TBL] [Abstract][Full Text] [Related]
14. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
Jakubczak JL; Chisari FV; Merlino G
Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035
[TBL] [Abstract][Full Text] [Related]
15. Hepatic tumor induction in c-myc mono-transgenic and TGF-alpha/c-myc double-transgenic mice.
Thorgeirsson SS; Santoni-Rugiu E; Davis CD; Snyderwine EG
Arch Toxicol Suppl; 1997; 19():359-66. PubMed ID: 9079223
[TBL] [Abstract][Full Text] [Related]
16. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.
Sanders S; Thorgeirsson SS
Mol Carcinog; 2000 Jul; 28(3):168-73. PubMed ID: 10942533
[TBL] [Abstract][Full Text] [Related]
17. Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.
Kao CY; Factor VM; Thorgeirsson SS
Biochem Biophys Res Commun; 1996 May; 222(1):64-70. PubMed ID: 8630075
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
Murakami H; Sanderson ND; Nagy P; Marino PA; Merlino G; Thorgeirsson SS
Cancer Res; 1993 Apr; 53(8):1719-23. PubMed ID: 8467484
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
[TBL] [Abstract][Full Text] [Related]
20. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS
Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
